Differentiation-inducing factor-1 enhances 5-fluorouracil action on oral cancer cells inhibiting E2F1 and thymidylate synthase mRNAs accumulation

Cancer Chemotherapy and Pharmacology

Volumn 69, Issue 4, 2012, Pages 983-989

  Sprio, Andrea Elio ^a   Di Scipio, Federica ^a   Ceppi, Paolo ^a   Salamone, Paolina ^a   Di Carlo, Francesco ^a   Scagliotti, Giorgio Vittorio ^a   Papotti, Mauro ^a   Ceccarelli, Adriano ^a   Berta, Giovanni Nicolao ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Differentiation inducing factor; E2F1; Oral cancer; Thymidylate synthase

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; DIFFERENTIATION INDUCING FACTOR; DIFFERENTIATION INDUCING FACTOR 1; FLUOROURACIL; MESSENGER RNA; UNCLASSIFIED DRUG;

ADENOSQUAMOUS CARCINOMA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG POTENTIATION; E2F1 GENE; GENE EXPRESSION REGULATION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MOUTH CARCINOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; THYMIDYLATE SYNTHASE GENE; TUMOR GENE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL SURVIVAL; DRUG SYNERGISM; E2F1 TRANSCRIPTION FACTOR; FLUOROURACIL; GENE EXPRESSION; HEXANONES; HUMANS; MOUTH NEOPLASMS; RNA, MESSENGER; SIGNAL TRANSDUCTION; THYMIDYLATE SYNTHASE;

EID: 84859797911     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-011-1790-x     Document Type: Article

References (28)

1. Morris HR, Taylor GW, Masento MS, Jermyn KA, Kay RR (1987) Chemical structure of the morphogen differentiation inducing factor from Dictyostelium discoideum. Nature 328(6133):811-814 (Pubitemid 17125958)
2. Fukuzawa M, Abe T, Williams JG (2003) The Dictyostelium prestalk cell inducer DIF regulates nuclear accumulation of a STAT protein by controlling its rate of export from the nucleus. Development 130(4):797-804 (Pubitemid 36240587)
3. Zhukovskaya NV, Fukuzawa M, Yamada Y, Araki T, Williams JG (2006) The Dictyostelium bZIP transcription factor DimB regulates prestalk-specific gene expression. Development 133(3): 439-448 (Pubitemid 43273830)
4. MacWilliams H, Doquang K, Pedrola R, Dollman G, Grassi D, Peis T, Tsang A, Ceccarelli A (2006) A retinoblastoma ortholog controls stalk/spore preference in Dictyostelium. Development 133(7):1287-1297
5. Kubohara Y (1999) Effects of differentiation-inducing factors of Dictyostelium discoideum on human leukemia K562 cells: DIF-3 is the most potent anti-leukemic agent. Eur J Pharmacol 381(1): 57-62
6. Kanai M, Konda Y, Nakajima T, Izumi Y, Kanda N, Nanakin A, Kubohara Y, Chiba T (2003) Differentiation-inducing factor-1 (DIF-1) inhibits STAT3 activity involved in gastric cancer cell proliferation via MEK-ERK-dependent pathway. Oncogene 22(4): 548-554 (Pubitemid 36188612)
7. Mori J, Takahashi-Yanaga F, Miwa Y, Watanabe Y, Hirata M, Morimoto S, Shirasuna K, Sasaguri T (2005) Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr286 in squamous cell carcinoma. Exp Cell Res 310(2):426-433 (Pubitemid 41457345)
8. Yasmin T, Takahashi-Yanaga F, Mori J, Miwa Y, Hirata M, Watanabe Y, Morimoto S, Sasaguri T (2005) Differentiation-inducing factor-1 suppresses gene expression of cyclin D1 in tumor cells. Biochem Biophys Res Commun 338(2):903-909 (Pubitemid 41597727)
9. Takahashi-Yanaga F, Taba Y, Miwa Y, Kubohara Y, Watanabe Y, Hirata M, Morimoto S, Sasaguri T (2003) Dictyostelium differentiation- inducing factor-3 activates glycogen synthase kinase- 3beta and degrades cyclin D1 in mammalian cells. J Biol Chem 278(11):9663-9670 (Pubitemid 36800463)
10. Du W, Pogoriler J (2006) Retinoblastoma family genes. Oncogene 25(38):5190-5200 (Pubitemid 44299077)
11. Giacinti C, Giordano A (2006) RB and cell cycle progression. Oncogene 25(38):5220-5227 (Pubitemid 44299080)
12. Abramova MV, Zatulovskiy EA, Svetlikova SB, Kukushkin AN, Pospelov VA (2010) e2f1 Gene is a new member of Wnt/beta-catenin/ Tcf-regulated genes. Biochem Biophys Res Commun 391(1):142-146
13. Angus SP, Wheeler LJ, Ranmal SA, Zhang X, Markey MP, Mathews CK, Knudsen ES (2002) Retinoblastoma tumor suppressor targets dNTP metabolism to regulate DNA replication. J Biol Chem 277(46):44376-44384 (Pubitemid 36157873)
14. Duffy MJ (2005) Predictive markers in breast and other cancers: a review. Clin Chem 51(3):494-503
15. Lehman NL (2002) Future potential of thymidylate synthase inhibitors in cancer therapy. Expert Opin Investig Drugs 11(12):1775-1787
16. Gioanni J, Fischel JL, Lambert JC, Demard F, Mazeau C, Zanghellini E, Ettore F, Formento P, Chauvel P, Lalanne CM (1988) Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment. Eur J Cancer Clin Oncol 24(9):1445-1455
17. Jiang L, Ji N, Zhou Y, Li J, Liu X, Wang Z, Chen Q, Zeng X (2009) CAL 27 is an oral adenosquamous carcinoma cell line. Oral Oncol 45(11):e204-e207. doi:10.1016/j.oraloncology.2009.06.001
18. Momose F, Araida T, Negishi A, Ichijo H, Shioda S, Sasaki S (1989) Variant sublines with different metastatic potentials selected in nude mice from human oral squamous cell carcinomas. J Oral Pathol Med 18(7):391-395 (Pubitemid 20001923)
19. Smulow JB, Glickman I (1966) An epithelial-like cell line in continuous culture from normal adult human gingiva. Proc Soc Exp Biol Med 121(4):1294-1296
20. Monica V, Scagliotti GV, Ceppi P, Righi L, Cambieri A, Lo Iacono M, Saviozzi S, Volante M, Novello S, Papotti M (2009) Differential thymidylate synthase expression in different variants of large-cell carcinoma of the lung. Clin Cancer Res 15(24):7547-7552
21. Barker N (2008) The canonical Wnt/beta-catenin signalling pathway. Methods Mol Biol 468(5):5-15
22. Liu F, Millar SE (2010) Wnt/beta-catenin signaling in oral tissue development and disease. J Dent Res 89(4):318-330
23. Lenz HJ, Leichman CG, Danenberg KD, Danenberg PV, Groshen S, Cohen H, Laine L, Crookes P, Silberman H, Baranda J, Garcia Y, Li J, Leichman L (1996) Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. J Clin Oncol 14(1):176-182 (Pubitemid 26020011)
24. Wada Y, Yoshida K, Suzuki T, Mizuiri H, Konishi K, Ukon K, Tanabe K, Sakata Y, Fukushima M (2006) Synergistic effects of docetaxel and S-1 by modulating the expression of metabolic enzymes of 5-fluorouracil in human gastric cancer cell lines. Int J Cancer 119(4):783-791 (Pubitemid 44055889)
25. Shigematsu H, Yoshida K, Sanada Y, Osada S, Takahashi T, Wada Y, Konishi K, Okada M, Fukushima M (2010) Rapamycin enhances chemotherapy-induced cytotoxicity by inhibiting the expressions of TS and ERK in gastric cancer cells. Int J Cancer 126(11):2716-2725
26. Akaishi E, Narita T, Kawai S, Miwa Y, Sasaguri T, Hosaka K, Kubohara Y (2004) Differentiation-inducing factor-1-induced growth arrest of K562 leukemia cells involves the reduction of ERK1/2 activity. Eur J Pharmacol 485(1-3):21-29 (Pubitemid 38134394)
27. Kubohara Y (1997) DIF-1, putative morphogen of D. discoideum, suppresses cell growth and promotes retinoic acid-induced cell differentiation in HL-60. Biochem Biophys Res Commun 236(2):418-422
28. Miwa Y, Sasaguri T, Kosaka C, Taba Y, Ishida A, Abumiya T, Kubohara Y (2000) Differentiation-inducing factor-1, a morphogen of dictyostelium, induces G(1) arrest and differentiation of vascular smooth muscle cells. Circ Res 86(1):68-75 (Pubitemid 30044170)